This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: University System of Maryland. Active years: 2016-2024.
Location History:
- Cockeysville, MD (US) (2016 - 2021)
- Cockeyville, MD (US) (2024)
Company Filing History:
Years Active: 2016-2024
Title: Innovations by Eduardo Davila in Cancer Treatment
Introduction
Eduardo Davila is a prominent inventor based in Cockeysville, MD (US). He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 5 patents, Davila is recognized for his work in developing advanced therapeutic systems.
Latest Patents
One of Davila's latest patents is titled "Universal anti-tag chimeric antigen receptor-expressing T cells and methods of treating cancer." This invention provides a universal, yet adaptable, anti-tag chimeric antigen receptor (AT-CAR) system. It enables T cells to recognize and kill target cells, such as tumor cells, that have been marked by tagged antibodies. For instance, αFITC-CAR-expressing T cells have been developed to specifically recognize various human cancer cells when those cells are bound by cancer-reactive FITC-labeled antibodies. The activation of αFITC-CAR-expressing T cells induces efficient target lysis, T cell proliferation, and cytokine/chemokine production. This innovative system can be utilized for treating subjects with cancer.
Career Highlights
Eduardo Davila is affiliated with the University System of Maryland, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
Davila collaborates with notable colleagues, including Koji Tamada, who share his commitment to advancing cancer treatment technologies.
Conclusion
Eduardo Davila's innovative contributions to cancer treatment through his patented technologies highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic approaches that could significantly improve patient outcomes.